Oruka Therapeutics reports positive week 28 results for ORKA-001 in plaque psoriasis; shares fall premarket

Oruka Therapeutics reported positive week 28 results for ORKA-001 in plaque psoriasis. The stock was down about 4.8% in premarket trading following the data.

Detected & updated continuously · Source: Nebula